Catalyst Pharmaceutical
CPRX
CPRX
361 hedge funds and large institutions have $2.2B invested in Catalyst Pharmaceutical in 2025 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 159 increasing their positions, 123 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
8% less capital invested
Capital invested by funds: $2.39B → $2.2B (-$188M)
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
94% less call options, than puts
Call options by funds: $403K | Put options by funds: $6.2M
Holders
361
Holding in Top 10
2
Calls
$403K
Puts
$6.2M
Top Buyers
| 1 | +$26.7M | |
| 2 | +$17.1M | |
| 3 | +$12.1M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$12M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$9.37M |
Top Sellers
| 1 | -$15.7M | |
| 2 | -$11.8M | |
| 3 | -$9.23M | |
| 4 |
NVCHI
New Vernon Capital Holdings II
Morristown,
New Jersey
|
-$6.82M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$6.07M |
